Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FICD | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | MTHFS | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | MT-ND4L | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | ERCC6L | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | HS1BP3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | KIR2DL4 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | PAN3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | NIM1K | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | ST20-MTHFS | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | ATG16L2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |